<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">17868791</PMID>
        <DateCompleted>
            <Year>2007</Year>
            <Month>12</Month>
            <Day>11</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2018</Year>
            <Month>11</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Print">0270-9295</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>27</Volume>
                    <Issue>5</Issue>
                    <PubDate>
                        <Year>2007</Year>
                        <Month>Sep</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Seminars in nephrology</Title>
                <ISOAbbreviation>Semin Nephrol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Ambulatory blood pressure and cardiovascular events in chronic kidney disease.</ArticleTitle>
            <Pagination>
                <MedlinePgn>538-43</MedlinePgn>
            </Pagination>
            <Abstract>
                <AbstractText>Hypertension is an important risk factor for adverse cardiovascular and renal outcomes, particularly in patients with chronic kidney disease (CKD). This review compares blood pressure (BP) measurements obtained in the clinic with those obtained outside the clinic to predict cardiovascular and renal injury and outcomes. Data are accumulating that suggest that ambulatory BP monitoring is a superior prognostic marker compared with BP values obtained in the clinic. The use of ambulatory BP monitoring can detect white-coat hypertension and masked hypertension, which results in less misclassification of BPs. Ambulatory BP monitoring is a marker of cardiovascular end points in CKD. Nondipping is associated with proteinuria and lower glomerular filtration rate. Although nondipping is associated with more end-stage renal disease and cardiovascular events, adjustment for other risk factors removes the prognostic significance of nondipping. For patients with CKD who are not on dialysis, 24-hour ambulatory BPs of less than 125/75 mm Hg, daytime ambulatory BP of less than 130/85 mm Hg, and nighttime ambulatory BPs of less than 110/70 mm Hg appear to be reasonable goal BP targets. In the management of hypertension in patients with CKD, control of hypertension is important. Ambulatory BP monitoring may be useful to assign more aggressive treatment to patients with masked hypertension and withdraw antihypertensive therapy in patients with white-coat hypertension. Ambulatory BP monitoring can refine cardiovascular and renal risk assessment in all stages of CKD. The independent prognostic role of nondipping is unclear.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Agarwal</LastName>
                    <ForeName>Rajiv</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Indiana University School of Medicine and Richard L. Roudebush VA Medical Center, Indianapolis, IN 46202, USA. ragarwal@iupui.edu</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>I01 CX000829</GrantID>
                    <Acronym>CX</Acronym>
                    <Agency>CSRD VA</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>R01 DK062030</GrantID>
                    <Acronym>DK</Acronym>
                    <Agency>NIDDK NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>R01 DK062030-04</GrantID>
                    <Acronym>DK</Acronym>
                    <Agency>NIDDK NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Semin Nephrol</MedlineTA>
            <NlmUniqueID>8110298</NlmUniqueID>
            <ISSNLinking>0270-9295</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D001794" MajorTopicYN="N">Blood Pressure</DescriptorName>
                <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D018660" MajorTopicYN="N">Blood Pressure Monitoring, Ambulatory</DescriptorName>
                <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002318" MajorTopicYN="N">Cardiovascular Diseases</DescriptorName>
                <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
                <QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007676" MajorTopicYN="N">Kidney Failure, Chronic</DescriptorName>
                <QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
                <QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
        <NumberOfReferences>21</NumberOfReferences>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2007</Year>
                <Month>9</Month>
                <Day>18</Day>
                <Hour>9</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2007</Year>
                <Month>12</Month>
                <Day>12</Day>
                <Hour>9</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2007</Year>
                <Month>9</Month>
                <Day>18</Day>
                <Hour>9</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">17868791</ArticleId>
            <ArticleId IdType="pii">S0270-9295(07)00086-1</ArticleId>
            <ArticleId IdType="doi">10.1016/j.semnephrol.2007.07.001</ArticleId>
            <ArticleId IdType="pmc">PMC2020449</ArticleId>
            <ArticleId IdType="mid">NIHMS31199</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>JAMA. 2003 May 21;289(19):2560-72</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12748199</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2004 Mar 17;291(11):1342-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15026401</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 1988 Jan 8;259(2):225-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">3336140</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Nephrol. 1995 Jun;43(6):382-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7554522</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Hypertens. 1995 Aug;8(8):790-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7576395</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hypertension. 2005 Jan;45(1):142-61</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15611362</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Kidney Dis. 2005 Jun;45(6):994-1001</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15957127</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Kidney Int. 2005 Sep;68(3):1294-302</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16105064</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hypertension. 2005 Sep;46(3):514-20</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16103271</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Kidney Int. 2006 Mar;69(5):900-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16518349</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Kidney Int. 2006 Apr;69(7):1175-80</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16467785</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Arch Intern Med. 2006 Apr 24;166(8):846-52</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16636209</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Nephrol. 2006;26(5):503-10</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17124383</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hypertension. 2007 Apr;49(4):777-83</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17261645</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Circulation. 2007 Apr 24;115(16):2145-52</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17420350</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Kidney Int. 2000 Jun;57(6):2485-91</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10844617</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Arch Intern Med. 2001 May 14;161(9):1207-16</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11343443</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hypertension. 2002 Dec;40(6):795-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12468559</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Blood Press Monit. 2002 Dec;7(6):293-300</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12488648</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2002 Dec 14;360(9349):1903-13</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12493255</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nephrol Dial Transplant. 2003 Mar;18(3):563-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12584280</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>
